Bilateral Ovarian Metastases from ALK Rearranged Non-Small Cell Lung Cancer

@inproceedings{Lee2014BilateralOM,
  title={Bilateral Ovarian Metastases from ALK Rearranged Non-Small Cell Lung Cancer},
  author={Kyung Ann Lee and Jong Sik Lee and Jae Ki Min and Hee J. Kim and Wan Seop Kim and Kye Young Lee},
  booktitle={Tuberculosis and respiratory diseases},
  year={2014}
}
Anaplastic lymphoma kinase (ALK) rearrangement, is a kind of driver mutation, accounts for 3%-5% of non-small cell lung cancer (NSCLC). NSCLC patients harboring ALK fusion genes have distinct clinical features and good response to ALK inhibitors. Metastasis from lung cancer to the ovary has rarely been known. We report a case of a 54-year-old woman with bilateral ovarian metastases from ALK rearranged NSCLC. She underwent bilateral salpingo-oophorectomy for ovary masses, which were progressed… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 12 references

Cystic brain metastasis in non-small-cell lung cancer with ALK rearrangement.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2014
View 2 Excerpts

Worse disease-free survival in never-smokers with ALK+ lung adenocarcinoma.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer • 2012

Similar Papers

Loading similar papers…